Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2016-07-28, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CO/20160728/20-F/1/000.htm SEC Original: a16-7975_120f.htm
FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China

---

---

Webplus: CO/20160728/20-F/2_EX-8.1/000.htm SEC Original: a16-7975_1ex8d1.htm
List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem

---

---

Webplus: CO/20160728/20-F/3_EX-12.1/000.htm SEC Original: a16-7975_1ex12d1.htm
Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CO/20160728/20-F/4_EX-12.2/000.htm SEC Original: a16-7975_1ex12d2.htm
Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CO/20160728/20-F/5_EX-13.1/000.htm SEC Original: a16-7975_1ex13d1.htm
Certification CHINA CORD BLOOD CORPORATION July 28, 2016 Ting Zheng Chief Executive Officer July 28, 2016 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a16-7975_1ex13d1.htm EX-13.1

---

---

Webplus: CO/20160728/20-F/6_EX-15.1/000.htm SEC Original: a16-7975_1ex15d1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,

---

---

Webplus: CO/20160728/20-F/7_EX-15.2/000.htm SEC Original: a16-7975_1ex15d2.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,

---

---

Webplus: CO/20160728/20-F/8_EX-15.3/000.htm SEC Original: a16-7975_1ex15d3.htm
Letter from Independent Registered Public Accounting Firm Ladies and Gentlemen: We were previously principal accountants for China Cord Blood Corporation and, under the date of July 31, 2015, we reported on the consolidated financial statements of China Cord Blood Corporation as of March 31, 2014 and 2015 and for each of the years in the three-year period ended March 31,

---

Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2016-07-28, XBRL Interactive FinancialsCIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000